Details of patients, presenting diseases, procedure performed, duration of follow up, and immunosuppression
| Patient age at graft (years), sex | Indication for limbal allograft | Procedure | Duration follow up (months) | Immunosuppression, duration treatment | ||||
| (A) 50, M | Epithelial dysplasia affecting both eyes and skin | R 360° limbal allograft | 36 | prednisolone phosphate 0.5% qds, 4 months | ||||
| (B) 34, F | Aniridic keratopathy, worse in right eye (primary limbal failure) | R 360° limbal allograft | 45 | prednisolone phosphate 0.5% qds, 13 months | ||||
| (C) 71, M | Limbal carcinoma in situ, biopsy proved recurrence, previous limbal graft failure | R 360° limbal allograft; corneal surface replaced | 54 | prednisolone phosphate 0.5% qds, 4 months | ||||
| prednisolone phosphate 0.5% bd, 50 months | ||||||||
| (D) 47, F | Contact lens induced limbal failure | R limbal allograft 2 × 3 clock hours | 56 | prednisolone phosphate 0.5% qds, 28 months | ||||
| cyclosporin 200–100 mg bd, 56 months | ||||||||
| azathioprine 100–25 mg od, 15 months | ||||||||
| (E) 67, M | Subtarsal well differentiated squamous cell carcinoma with invasive foci | L upper lid tarsoconjunctival allograft; corneal surface replaced | 56 | prednisolone phosphate 0.5% qds, 1 week | ||||
| prednisolone phosphate 0.5% tds, 11 months | ||||||||
| mitomycin C 0.02% od, alternate weeks | ||||||||
qds = four times daily; bd = twice daily; od = once daily; tds = three times daily.